Skip to content
← Back to newsCoreWeave's $9B Core Scientific Acquisition Sparks Analyst Doubts and Stock Dip
Opinion

CoreWeave's $9B Core Scientific Acquisition Sparks Analyst Doubts and Stock Dip

By ToTo BugelmanNewcomer0 rep· 7/9/2025

CoreWeave's recent acquisition of Core Scientific for $9 billion in an all-stock deal has sent ripples through the market, causing CoreWeave's stock to dip and raising significant concerns among analysts. The move, intended to bolster CoreWeave's AI and high-performance computing capabilities, is being scrutinized for its financial implications and the inherent volatility of Core Scientific's Bitcoin mining business.

 

CoreWeave's Strategic Play and Market Reaction

CoreWeave's acquisition of Core Scientific is a strategic maneuver aimed at vertical integration, securing 590 MW of direct current capacity for its AI and HPC workloads. This partnership is expected to address CoreWeave's need for scalable data center infrastructure and potentially reduce its cost of capital. However, the market's immediate reaction was negative, with CoreWeave's stock (CRWV) opening lower and dipping by 3.6% after the announcement.

  • Analysts like D.A. Davidson's Gil Luria questioned the deal's immediate profit contribution to CoreWeave, suggesting it primarily secures Core Scientific's capacity.

  • Mizuho downgraded CoreWeave shares to "Neutral" from "Outperform," citing a balanced risk-reward profile after a significant rally.

 

Google Finance

 

Core Scientific's Pivotal Shift and Investor Concerns

For Core Scientific, the acquisition represents a significant pivot from its volatile Bitcoin mining operations towards the high-growth AI/HPC segment. While this offers a guaranteed revenue stream, investors are wary of the terms and Core Scientific's financial health.

  • Core Scientific shareholders are set to receive 0.1235 shares of newly issued CoreWeave Class A common stock for each CORZ share, leading to concerns about diluted ownership.

  • Oppenheimer downgraded Core Scientific from "Outperform" to "Market Perform," and Roth Capital followed suit, downgrading to "Neutral" with a $20 price target.

  • Core Scientific's stock (CORZ) experienced a significant premarket slide of 17.2% following the news.

 

Financial Health and Analyst Divisions

Core Scientific's recent financials show a mixed picture, with a strong current ratio but also a significant year-over-year revenue decline and a negative net profit margin. Analysts remain divided on the deal's potential.

  • Jefferies (Buy): Highlights Core Scientific's post-bankruptcy restructuring, a $2.0 billion cumulative revenue pipeline from AI/HPC contracts, and strong liquidity. They argue the stock is undervalued relative to its AI growth prospects, with a takeout valuation range of $16-$23 per share.

  • Spark Capital (Neutral): Warns of execution risks, including Core Scientific's $400 million debt load and a negative P/E ratio due to recent losses. They caution that projected synergies may not materialize.

 

Insider Activity and Risks

Insider trading activity presents mixed signals, with a director increasing their stake while the CEO sold shares earlier in the year. The acquisition also faces several risks:

  • Deal Uncertainty: The acquisition remains unconfirmed, with regulatory hurdles and CoreWeave's financing plans still unclear.

  • Financial Health: Despite strong liquidity, Core Scientific's 55.6% YoY revenue decline in Q1 2025 and reliance on volatile Bitcoin prices pose near-term risks.

  • Valuation Skepticism: Bulls see potential in the AI/HPC market, while bears point to the significant drop in Bitcoin prices since 2021, which could strain profitability.

CoreWeave's acquisition of Core Scientific is a high-stakes gamble with potential for significant upside if synergies are realized, but it is also fraught with financial and market uncertainties.

 

Sources

 

This article was created with support from AI-driven technology, drawing on multiple reputable sources. The final content has been thoroughly reviewed and edited by BlockzHub's editorial team to ensure accuracy, clarity, and coherence. Original reporting sources are credited whenever appropriate and as required. The opinions expressed in this article do not necessarily represent the official views or positions of BlockzHub. This article is intended for informational purposes only and should not be considered financial or professional advice. Investing involves risk, and you should consult a qualified financial advisor before making any investment decisions.

Discussion (0)

Sign in to join the discussion.

No comments yet. Be the first.

CoreWeave's $9B Core Scientific Acquisition Sparks Analyst Doubts and Stock Dip | BlockzHub